Tilray Brands Inc header image

Tilray Brands Inc

TLRY

Equity

ISIN null / Valor 42386407

NASDAQ (2026-08-05)
USD 4.42-4.63%

Tilray Brands Inc
UMushroom community rating:

star star star star star
2.50 2 votes No rating yet
NegativeNeutralPositive

About company

Tilray Brands Inc. is a global pioneer in the research, cultivation, production, and distribution of cannabis and cannabinoids. The company prides itself on a scientific approach to product development, emphasizing active ingredients, standardized preparations, and consistent, measured dosing. Tilray's product portfolio is rigorously tested for potency and purity, ensuring high-quality offerings across various categories, including medicinal and recreational cannabis. Under the leadership of CEO Irwin D. Simon, who has over 30 years of experience in building consumer packaged goods companies, Tilray has positioned itself as a leader in the global cannabis market. Simon's previous success in transforming Aphria Inc. into a profitable entity and his foundational role at The Hain Celestial Group highlight his capability to steer Tilray towards significant growth and market share. The company's operational excellence spans from cultivation to shipping, with a focus on precision, professionalism, and care at every stage of the process, aiming to deliver unparalleled products to its patients and consumers.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-30.4%1Y
-80.8%3Y
-96.9%5Y

Performance

113%1Y
94.7%3Y
90.3%5Y

Volatility

Market cap

603 M

Market cap (USD)

Daily traded volume (Shares)

4,652,563

Daily traded volume (Shares)

1 day high/low

1.415 / 1.33

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

2.50

2 votes
Performance:
starstarstarstarstar
2.00
Innovation:
starstarstarstarstar
3.00
Society:
starstarstarstarstar
2.50
Nature:
starstarstarstarstar
2.50
Robin Roten
Switzerland, 04 Dec 2022
star star star star star
Tej Ram Kumpakha
Switzerland, 25 Mar 2022
star star star star star
Though the company is not successful yet to achieve the positive net profit; the share price is likely to increase mainly due the House Rules Committee voting on legalizing Cannabis.

EQUITIES OF THE SAME SECTOR

Bausch Health Companies Inc
Bausch Health Companies Inc Bausch Health Companies Inc Valor: 42260834
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.71%USD 6.28
Cassava Sciences Inc
Cassava Sciences Inc Cassava Sciences Inc Valor: 46983284
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-3.67%USD 0.96
Ligand Pharmaceuticals Inc
Ligand Pharmaceuticals Inc Ligand Pharmaceuticals Inc Valor: 12015449
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.59%USD 302.57
RadNet Inc
RadNet Inc RadNet Inc Valor: 2812237
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-3.12%USD 67.06
Allogene Therapeutics Inc
Allogene Therapeutics Inc Allogene Therapeutics Inc Valor: 43756548
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.63%USD 1.95
Healthcare Services Group Inc
Healthcare Services Group Inc Healthcare Services Group Inc Valor: 938239
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.34%USD 22.84
Janux Therapeutics Inc
Janux Therapeutics Inc Janux Therapeutics Inc Valor: 111742522
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.25%USD 16.00
Hikma Pharmaceuticals PLC
Hikma Pharmaceuticals PLC Hikma Pharmaceuticals PLC Valor: 2324471
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.63%GBP 15.71
Dermapharm Holding SE
Dermapharm Holding SE Dermapharm Holding SE Valor: 40166352
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.60%EUR 41.15
RHOEN-KLINIKUM AG
RHOEN-KLINIKUM AG RHOEN-KLINIKUM AG Valor: 341644
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.56%EUR 12.60